LYNX1 CAPITAL MANAGEMENT LP
LYNX1 CAPITAL MANAGEMENT LP is a Series C+ fund in the US investing in healthcare-tech.
- Stages
- Series C+
- Sectors
- healthcare-tech
- Invests in
- US-wide
- Founded
- 2020
- Assets under management
- $632M
Check size not disclosed
Thesis
The firm invests in the stocks of U.S. biotechnology companies using a long bias equity strategy. As of March 31, 2026, the portfolio value was $632,718,355 USD. The firm manages three hedge funds: Lynx1 Master Fund, Lynx1 Offshore Fund, and Lynx1 Onshore Fund. Lynx1 Onshore Fund LP was organized in 2020.
Common questions
Does LYNX1 CAPITAL MANAGEMENT LP invest at the Series C+ stage?
Yes. LYNX1 CAPITAL MANAGEMENT LP lists Series C+ among the stages it invests in.
Where does LYNX1 CAPITAL MANAGEMENT LP invest?
LYNX1 CAPITAL MANAGEMENT LP invests in the US.